BNT162b2 mRNA COVID-19 against symptomatic Omicron Infection following a mass vaccination campaign in southern Brazil: a prospective test-negative design study
Trial Registration Number - ID: NCT05052307
FernandaKelly/BNT162b2-Pfizer-BioNTech-mRNA-COVID-19
Folders and files
| Name | Name | Last commit date | ||
|---|---|---|---|---|